Successful reinduction therapy with amsacrine and cyclocytidine in acute nonlymphoblastic leukemia in children. A report from the childrens cancer study group

This publication has 9 references indexed in Scilit:

• Intermediate-dose cytosine arabinoside and amsacrine an effective regimen with low toxicity in refractory acute nonlymphocytic leukemia
  Cancer, 1990
• Results of induction and consolidation treatment with intermediate and high‐dose cytosine arabinoside and m‐Amsa of patients with poor‐risk acute myelogeneous leukaemia
  European Journal of Haematology, 1988
• Etoposide (VP-16–213)
  New England Journal of Medicine, 1985
• Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: A report from children's cancer study group
  Medical and Pediatric Oncology, 1983
• Current status of the biology and treatment of acute non-lymphocytic leukemia in children (report from the ANLL strategy group of the Children's Cancer Study Group
  Blood, 1983
• Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults
  Blood, 1982
• Characteristics of children with acute nonlymphocytic leukemia in long-term continuous remission: A report for childrens cancer study group
  Medical and Pediatric Oncology, 1981
• Reporting results of cancer treatment
  Cancer, 1981
• Treatment of Acute Myelogenous Leukemia in Children and Adults
  New England Journal of Medicine, 1980